Cargando…

How effective is tetracaine 4% gel, before a venipuncture, in reducing procedural pain in infants: a randomized double-blind placebo controlled trial

BACKGROUND: Procedural pain relief is sub-optimal in neonates. Topical tetracaine provides pain relief in children. Evidence of its efficacy and safety in neonates is limited. The objective of this study was to assess the efficacy and safety of topical tetracaine on the pain response of neonates dur...

Descripción completa

Detalles Bibliográficos
Autores principales: Lemyre, Brigitte, Hogan, Debora L, Gaboury, Isabelle, Sherlock, Rebecca, Blanchard, Colline, Moher, David
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1800845/
https://www.ncbi.nlm.nih.gov/pubmed/17288611
http://dx.doi.org/10.1186/1471-2431-7-7
_version_ 1782132348875177984
author Lemyre, Brigitte
Hogan, Debora L
Gaboury, Isabelle
Sherlock, Rebecca
Blanchard, Colline
Moher, David
author_facet Lemyre, Brigitte
Hogan, Debora L
Gaboury, Isabelle
Sherlock, Rebecca
Blanchard, Colline
Moher, David
author_sort Lemyre, Brigitte
collection PubMed
description BACKGROUND: Procedural pain relief is sub-optimal in neonates. Topical tetracaine provides pain relief in children. Evidence of its efficacy and safety in neonates is limited. The objective of this study was to assess the efficacy and safety of topical tetracaine on the pain response of neonates during a venipuncture. METHODS: Medically stable infants greater than or equal to 24 weeks gestation, requiring a venipuncture, were included. Following randomization and double blinding, 1.1 g of tetracaine or placebo was applied to the skin for 30 minutes. Participants received oral sucrose if they met local eligibility criteria. The venipuncture was performed according to a standard protocol. A medium effect size in the pain score (corresponding to about 2 point difference in the PIPP score) was considered clinically significant, leading to a sample size of 142 infants, with 80% statistical power. Local skin reactions and immediate adverse cardiorespiratory events were noted. The primary outcome, PIPP score at 1 minute, was analysed using an independent Student's t-test. RESULTS: One hundred and forty two infants were included, 33 +/- 4 weeks gestation, 2100 +/- 900 grams and 6 +/- 3 days of age. There was almost no difference in PIPP scores at 1 minute between groups (mean difference -0.09; 95% confidence interval [CI]: -1.68 to 1.50; P = . 91). Similarly, there were no differences in PIPP scores during the 2(nd), 3(rd )and 4th minute. Duration of cry did not differ between the groups (median difference, 0; 95% CI, -3 to 0; P = . 84). The majority of infants in both groups received sucrose 24%. Sucrose had a significant effect on the PIPP score, as assessed by an ANOVA model (p = 0.0026). Local skin erythema was observed transiently in 11 infants (7 in the tetracaine and 4 in the placebo group). No serious side effect was observed. CONCLUSION: Tetracaine did not significantly decrease procedural pain in infants undergoing a venipuncture, when used in combination with routine sucrose administration.
format Text
id pubmed-1800845
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-18008452007-02-17 How effective is tetracaine 4% gel, before a venipuncture, in reducing procedural pain in infants: a randomized double-blind placebo controlled trial Lemyre, Brigitte Hogan, Debora L Gaboury, Isabelle Sherlock, Rebecca Blanchard, Colline Moher, David BMC Pediatr Research Article BACKGROUND: Procedural pain relief is sub-optimal in neonates. Topical tetracaine provides pain relief in children. Evidence of its efficacy and safety in neonates is limited. The objective of this study was to assess the efficacy and safety of topical tetracaine on the pain response of neonates during a venipuncture. METHODS: Medically stable infants greater than or equal to 24 weeks gestation, requiring a venipuncture, were included. Following randomization and double blinding, 1.1 g of tetracaine or placebo was applied to the skin for 30 minutes. Participants received oral sucrose if they met local eligibility criteria. The venipuncture was performed according to a standard protocol. A medium effect size in the pain score (corresponding to about 2 point difference in the PIPP score) was considered clinically significant, leading to a sample size of 142 infants, with 80% statistical power. Local skin reactions and immediate adverse cardiorespiratory events were noted. The primary outcome, PIPP score at 1 minute, was analysed using an independent Student's t-test. RESULTS: One hundred and forty two infants were included, 33 +/- 4 weeks gestation, 2100 +/- 900 grams and 6 +/- 3 days of age. There was almost no difference in PIPP scores at 1 minute between groups (mean difference -0.09; 95% confidence interval [CI]: -1.68 to 1.50; P = . 91). Similarly, there were no differences in PIPP scores during the 2(nd), 3(rd )and 4th minute. Duration of cry did not differ between the groups (median difference, 0; 95% CI, -3 to 0; P = . 84). The majority of infants in both groups received sucrose 24%. Sucrose had a significant effect on the PIPP score, as assessed by an ANOVA model (p = 0.0026). Local skin erythema was observed transiently in 11 infants (7 in the tetracaine and 4 in the placebo group). No serious side effect was observed. CONCLUSION: Tetracaine did not significantly decrease procedural pain in infants undergoing a venipuncture, when used in combination with routine sucrose administration. BioMed Central 2007-02-08 /pmc/articles/PMC1800845/ /pubmed/17288611 http://dx.doi.org/10.1186/1471-2431-7-7 Text en Copyright © 2007 Lemyre et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Lemyre, Brigitte
Hogan, Debora L
Gaboury, Isabelle
Sherlock, Rebecca
Blanchard, Colline
Moher, David
How effective is tetracaine 4% gel, before a venipuncture, in reducing procedural pain in infants: a randomized double-blind placebo controlled trial
title How effective is tetracaine 4% gel, before a venipuncture, in reducing procedural pain in infants: a randomized double-blind placebo controlled trial
title_full How effective is tetracaine 4% gel, before a venipuncture, in reducing procedural pain in infants: a randomized double-blind placebo controlled trial
title_fullStr How effective is tetracaine 4% gel, before a venipuncture, in reducing procedural pain in infants: a randomized double-blind placebo controlled trial
title_full_unstemmed How effective is tetracaine 4% gel, before a venipuncture, in reducing procedural pain in infants: a randomized double-blind placebo controlled trial
title_short How effective is tetracaine 4% gel, before a venipuncture, in reducing procedural pain in infants: a randomized double-blind placebo controlled trial
title_sort how effective is tetracaine 4% gel, before a venipuncture, in reducing procedural pain in infants: a randomized double-blind placebo controlled trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1800845/
https://www.ncbi.nlm.nih.gov/pubmed/17288611
http://dx.doi.org/10.1186/1471-2431-7-7
work_keys_str_mv AT lemyrebrigitte howeffectiveistetracaine4gelbeforeavenipunctureinreducingproceduralpainininfantsarandomizeddoubleblindplacebocontrolledtrial
AT hogandeboral howeffectiveistetracaine4gelbeforeavenipunctureinreducingproceduralpainininfantsarandomizeddoubleblindplacebocontrolledtrial
AT gabouryisabelle howeffectiveistetracaine4gelbeforeavenipunctureinreducingproceduralpainininfantsarandomizeddoubleblindplacebocontrolledtrial
AT sherlockrebecca howeffectiveistetracaine4gelbeforeavenipunctureinreducingproceduralpainininfantsarandomizeddoubleblindplacebocontrolledtrial
AT blanchardcolline howeffectiveistetracaine4gelbeforeavenipunctureinreducingproceduralpainininfantsarandomizeddoubleblindplacebocontrolledtrial
AT moherdavid howeffectiveistetracaine4gelbeforeavenipunctureinreducingproceduralpainininfantsarandomizeddoubleblindplacebocontrolledtrial